title: The safety and efficacy of sertaconazole nitrate cream 2% for tinea pedis.
abstract: To determine the safety and efficacy of topical sertaconazole nitrate cream 2% in the treatment of tinea pedis, 2 randomized, multicenter, double-blinded, parallel group, vehicle-controlled studies were conducted. A total of 588 subjects were enrolled, and 383 subjects were randomized to treatment with sertaconazole or vehicle applied twice daily for 4 weeks. Improvements in symptoms were noted at week 1 in the active treatment group. At week 4, mycologic cure was seen in 70.3% of sertaconazole-treated subjects and 36.7% of vehicle-treated subjects (P<.0001). At week 6, 46.7% of sertaconazole-treated subjects had successful treatment outcomes compared with 14.9% of vehicle-treated subjects (P<.0001). No serious adverse events were reported, and rates of cutaneous adverse events were comparable between treatment groups. In conclusion, sertaconazole nitrate cream 2% was well-tolerated, offered rapid relief of symptoms, and achieved high rates of mycologic cure. The stability of the mycologic cure rates through weeks 5 and 6 (2 weeks after cessation of therapy) indicate that sertaconazole protects against reinfection.
authors.affiliation: Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut, USA. savinderm@snet.net
authors.forename: Ronald
authors.initials: R
authors.lastname: Savin
authors.forename: Joseph
authors.initials: J
authors.lastname: Jorizzo
mesh_terms: D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000935:Antifungal Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D004311:Double-Blind Method; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D009824:Ointments; D013876:Thiophenes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014008:Tinea Pedis / Q000188:drug therapy*; D016896:Treatment Outcome; D014481:United States
chemical_list: D000935:Antifungal Agents; D007093:Imidazoles; D009824:Ointments; D013876:Thiophenes; C061131:sertaconazole